WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
I
N
Vol. 39 No.3 • 5/2022
T
E
POC Test Speeds Up Sepsis Diagnostics
R
N
A
T
I
O
DAILY CLINICAL LAB NEWS
®
N
Painless Test Simplifies Diagnosis of Allergies and Predicts Success of Immunotherapy
S
epsis (blood poisoning) is a life-threatening condition that requires immediate medical attention. Early presentation and diagnosis is vital and can increase the chances of survival significantly. However, serious limitations in the current methods for
A
lthough allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear. Skin tests so far have been unpleasant, time-consuming and associated with a certain risk
of triggering an allergic overreaction. Researchers have now developed a novel test that massively simplifies the diagnosis of allergies and can reliably predict the success of a therapy. The allergy test developed by researchers at the University of
Cont’d on page 8
Cont’d on page 18
DNA Test Cuts Diagnosis Of Over 50 Genetic Diseases From Decades to Days
V
I
S
I
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
T
here are about 50 million people suffering from dementia worldwide. Alzheimer’s disease is the most common form and accounts for 6070% of cases. At present there are no disease modifying treatments for Alzheimer’s, and therapies to treat symptoms are limited. The lack of Cont’d on page 12
BioMerieux Acquisition to Expand Offerings in Antimicrobial Susceptibility Testing
A
Antibody Test Diagnoses MS in 20 Minutes
M
ultiple sclerosis (MS) is a disease that affects the brain and spinal cord, and can lead to deterioration and permanent damage of the nerves. While its cause is unknown, the disease triggers the immune system to attack the protective coating on nerve fibers. This disrupts signals between the brain and spinal cord. Symptoms vary widely. These symptoms depend on the
O
Non-Invasive Blood Test Can Accurately Diagnose Alzheimer’s
ntimicrobial Resistance (AMR) is a global threat, with infections from antibiotic resistant pathogens being one of the leading causes of death around the world. For clinicians to save patients’ lives and rapidly optimize therapies, fast
L
Personalized Cancer Monitoring Platform
Image: Neuronal inclusions in Huntington’s disease (3D illustration).
See article on page 4
A
Cont’d on page 10
A
new DNA test can screen a patient’s genome for a whole category of genetic neurological and neuromuscular diseases, including Huntington’s disease, muscular dystrophies and fragile X syndrome.
V I S I T
and accurate antimicrobial susceptibility test (AST) results and interpretation are critical. In addition to improving patient outcomes, rapid AST also reduces global AMR burdens by enabling the implementation of effective instiCont’d on page 22
ver the past several years, research has shown that minimal or molecular residual disease (MRD) monitoring can reliably identify lung cancer patients at high risk of relapse, detect post-surgical recurrence often earlier than standard imaging, assess therapy response, and potentially act as a surrogate for clinical trial endpoints. Now, a newly-available platform can help Cont’d on page 14
INSIDE
COVID-19 Update. . . . . 5 Clinical News. . . . . . 6-20 IFCC News. . . . . . . . . . 23 Product News . . . . . 4-20 Industry News . . . . . . . 21 Events Calendar . . . . . 26
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<